{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:56:35Z","timestamp":1793235395877,"version":"4.5.0"},"reference-count":51,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South. Afr. j. HIV med."],"abstract":"<jats:p>The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis (PrEP) guidelines in June 2012 for men who have sex with men (MSM) who are at risk of HIV infection. With the flurry of data that has been generated in PrEP clinical research since the first guideline, it became evident that there was a need to revise and expand the PrEP guidelines with new evidence of safety and efficacy of PrEP in several populations, including MSM, transgender persons, heterosexual men and women, HIV-serodiscordant couples and people who inject drugs. This need is particularly relevant following the World Health Organization (WHO) Consolidated Treatment Guidelines released in September 2015. These guidelines advise that PrEP is a highly effective, safe, biomedical option for HIV prevention that can be incorporated with other combination prevention strategies in Southern Africa, given the high prevalence of HIV in the region. PrEP should be tailored to populations at highest risk of HIV acquisition, whilst further data from studies in the region accrue to guide optimal deployment to realise the greatest impact regionally. PrEP may be used intermittently during periods of perceived HIV acquisition risk, rather than continually and lifelong, as is the case with antiretroviral treatment. Recognition and accurate measurement of potential risk in individuals and populations also warrants discussion, but are not extensively covered in these guidelines.<\/jats:p>","DOI":"10.4102\/sajhivmed.v17i1.455","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T10:02:56Z","timestamp":1458122576000},"source":"Crossref","is-referenced-by-count":84,"title":["Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection"],"prefix":"10.4102","volume":"17","author":[{"given":"Linda-Gail","family":"Bekker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Moorhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conradie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Harley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Eakle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"ref0001","author":"World Health Organization","year":"2015","journal-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV"},{"key":"ref0002","author":"Gilead Sciences","year":"2015","journal-title":"Truvada package insert"},{"key":"ref0003","doi-asserted-by":"publisher","DOI":"10.1126\/science.1116204"},{"key":"ref0004","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050157"},{"key":"ref0005","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050028"},{"key":"ref0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"ref0007","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31828ece33"},{"key":"ref0008","author":"McCormack","journal-title":"Pragmatic open-label randomised trial of preexposure prophylaxis: The PROUD Study"},{"key":"ref0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"ref0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"ref0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61127-7"},{"key":"ref0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402269"},{"key":"ref0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"ref0014","first-page":"1","author":"UNAIDS","year":"2011","journal-title":"UNAIDS terminology guidelines"},{"key":"ref0015","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040339"},{"key":"ref0016","doi-asserted-by":"crossref","DOI":"10.1596\/978-0-8213-8726-9","author":"Beyrer","year":"2011","journal-title":"The global HIV epidemics among men who have sex with men"},{"key":"ref0017","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010003"},{"key":"ref0018","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq057"},{"key":"ref0019","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009564"},{"key":"ref0020","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004997"},{"key":"ref0021","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-766"},{"key":"ref0022","doi-asserted-by":"publisher","DOI":"10.1071\/SH09090"},{"key":"ref0023","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-009-9598-y"},{"key":"ref0024","author":"Rispel","year":"2009","journal-title":"A rapid assesment of the HIV epidemic among men who have sex with men. Information leaflet"},{"key":"ref0025","author":"Desmond Tutu HIV Foundation","year":"2011","journal-title":"A gap analysis for key populations and HIV in South Africa"},{"key":"ref0026","author":"SACEMA","year":"2009","journal-title":"The modes of transmission of HIV in South Africa"},{"key":"ref0027","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-008-9389-x"},{"key":"ref0028","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2011.010350"},{"key":"ref0029","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.031500"},{"key":"ref0030","first-page":"19","volume":"21","author":"Nel","year":"2008","journal-title":"Acta Criminol"},{"key":"ref0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-8080(09)33442-4"},{"key":"ref0032","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.031567"},{"key":"ref0033","author":"CEGAA","year":"2011","journal-title":"South Africa Consolidated National AIDS Spending Assessment"},{"key":"ref0034","author":"South African National AIDS Council","year":"2011","journal-title":"South African HIV epidemic, response and policy synthesis"},{"key":"ref0035","doi-asserted-by":"publisher","DOI":"10.1057\/dev.2008.76"},{"key":"ref0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61118-1"},{"key":"ref0037","doi-asserted-by":"publisher","DOI":"10.1080\/09540120701842720"},{"key":"ref0038","first-page":"65","volume":"60","author":"United States Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref0039","author":"US Public Health Service","year":"2014","journal-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2014 clinical practice guideline"},{"key":"ref0040","author":"Clinical and Laboratory Standards Institute","year":"2013","journal-title":"Quality management system: Development and management of laboratory documents; approved guidelines"},{"key":"ref0041","author":"World Health Organization","year":"2011","journal-title":"Recommendations for a public health approach"},{"key":"ref0042","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0182-5"},{"key":"ref0043","doi-asserted-by":"publisher","DOI":"10.1086\/656412"},{"key":"ref0044","first-page":"6","volume":"24","author":"Lewis","year":"2009","journal-title":"S Afr J Epidemiol Infect"},{"key":"ref0045","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138315"},{"key":"ref0046","author":"World Health Organization","year":"c2014","journal-title":"Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations"},{"key":"ref0047","first-page":"22","author":"Gilbert","year":"2009","journal-title":"The Sandford guide to HIV\/AIDS therapy"},{"key":"ref0048","first-page":"185","author":"Wilson","year":"2002","journal-title":"Handbook of HIV medicine"},{"key":"ref0049","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023688"},{"key":"ref0050","author":"Mulligan","journal-title":"Effects of emtricitabine\/tenofovir on bone mineral density in seronegative men from 4 continents: DEXA results of the global iPrEx study"},{"key":"ref0051","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.16333"}],"container-title":["Southern African Journal of HIV Medicine"],"original-title":[],"link":[{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/455\/617","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/455\/612","content-type":"application\/octet-stream","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/455\/613","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/455\/608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/455\/608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T12:25:28Z","timestamp":1533212728000},"score":1,"resource":{"primary":{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/view\/455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,2,12]]}},"URL":"https:\/\/doi.org\/10.4102\/sajhivmed.v17i1.455","relation":{},"ISSN":["2078-6751","1608-9693"],"issn-type":[{"value":"2078-6751","type":"electronic"},{"value":"1608-9693","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,9]]}}}